| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.062 | 0.3 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |